For AI assistants & researchers — machine-readable summary of this page
What this page is: Delvantic's full research page for DocuSign Inc. (DOCU) — AI-driven forensic equity research: mechanical valuation models (DCF, EPV, anchored-PE, scenario) plus three independent AI lenses (Quality / Value / Sentiment). Everything below is rendered server-side; you are not missing content that requires JavaScript. All scores are predictions and research opinions, not financial advice.
Our current read (analysis of 2026-10-09): Designation Watch · Gem Score -12 (−100…+100 Quality+Value blend) · Quality 44 · Value -49 · Sentiment 23 (timing only, not weighted) · Composite fair value $68.26 vs $64.00 at analysis
Page map (sections in order; each card carries a stable
reference-name attribute you can cite):
profile-header/price-overview— company profile, live quote, market capextended-analysis— the core: three AI lens reads with findings, scores, and the analyst memofuture-predictions— our forward price-band predictionsmarket-narrative/ai-findings/gpt-critique— narrative context, cross-model findings, and an adversarial critique of our own analysis (near the end of the document)- Members-only sections (render as login gates for anonymous readers):
price-history,income-trend,key-metrics,financials(statement tables),insider-trading. The analysis above is public; the raw data tables require a free account.
More for machine readers: site briefing at
/llms.txt ·
any ticker resolves at delvantic.com/stock/TICKER ·
raw inputs are public-company filings and market data (via licensed data feeds);
every model, score, lens read, and prediction on this page is Delvantic's own analysis.
DocuSign Inc.
DOCU NASDAQDocuSign Inc. is a software company that provides Intelligent Agreement Management solutions for creating, signing, managing, and analyzing agreements. Its core offerings include eSignature, contract lifecycle management, identity verification, document generation, web forms, remote online notarization, and agreement analytics, all designed to streamline document-heavy business processes. DocuSign serves organizations across financial services, insurance, real estate, government, healthcare, and other industries, supporting legal, sales, procurement, human resources, and operations teams. The company’s platform is built to automate workflows, improve agreement visibility, and connect with widely used business systems through integrations and APIs. Based in San Francisco, DocuSign plays a central role in the digital transformation of agreement workflows for businesses of all sizes.
Price Overview
Price History (1 Year)
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): 1.48
Total Equity: $1.92B
Shares: 209,118,000
Total Debt: $0.00
Cash: $602.44M
EBITDA: $414.66M
Total Debt: $0.00
Cash: $602.44M
Revenue: $3.22B
Revenue: $3.22B
Revenue: $3.22B
Total Equity: $1.92B
Tax Rate: 11.0%
Equity: $1.92B
Total Debt: $0.00
Cash: $602.44M
Current Liabilities: $2.04B
Long-Term Debt: $0.00
Total Debt: $0.00
Total Equity: $1.92B
Shares: 209,118,000
Shares: 209,118,000
CapEx: -$106.45M
Shares: 209,118,000
Stock Price: $64.00
Net Income: $309.09M
Industry Benchmarks
Income Statement (Annual)
Last updated: Aug 31, 2026 2:36am (39d ago)| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | $2.1B | $2.5B | $2.8B | $3.0B | $3.2B |
| Cost of Revenue | $466.5M | $536.1M | $572.6M | $621.7M | $663.1M |
| Gross Profit | $1.6B | $2.0B | $2.2B | $2.4B | $2.6B |
| Operating Expenses | $1.7B | $2.1B | $2.2B | $2.2B | $2.3B |
| Operating Income | -$61.9M | -$88.0M | $31.6M | $199.9M | $298.6M |
| Net Income | -$70.0M | -$97.5M | $74.0M | $1.1B | $309.1M |
| EBITDA | $20.0M | -$1.8M | $126.7M | $307.7M | $414.7M |
| EPS | $-0.36 | $-0.49 | $0.36 | $5.23 | $1.53 |
| EPS (Diluted) | $-0.36 | $-0.49 | $0.36 | $5.08 | $1.48 |
Balance Sheet (Annual)
Last updated: Aug 31, 2026 2:30am (39d ago)| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $509.1M | $721.9M | $797.1M | $648.6M | $602.4M |
| Total Current Assets | $1.3B | $1.6B | $1.6B | $1.5B | $1.5B |
| Total Assets | $2.5B | $3.0B | $3.0B | $4.0B | $4.2B |
| Current Liabilities | $1.4B | $2.2B | $1.7B | $1.8B | $2.0B |
| Long-Term Debt | $718.5M | $0 | — | — | — |
| Total Liabilities | $2.3B | $2.4B | $1.8B | $2.0B | $2.3B |
| Total Equity | $275.5M | $617.3M | $1.1B | $2.0B | $1.9B |
| Retained Earnings | -$1.4B | -$1.6B | -$1.7B | -$1.3B | -$1.9B |
Cash Flow (Annual)
Last updated: Aug 31, 2026 2:48am (39d ago)| Metric | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $506.5M | $506.8M | $979.5M | $1.0B | $1.2B |
| Capital Expenditure | -$61.4M | -$77.7M | -$92.4M | -$97.0M | -$106.4M |
| Free Cash Flow | $445.1M | $429.1M | $887.1M | $920.3M | $1.1B |
| Acquisitions (net) | -$6.4M | $0 | $0 | -$143.6M | $0 |
| Net Debt Issued / (Repaid) | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | -$63.0M | -$145.5M | -$683.5M | -$869.1M |
| Net Change in Cash | -$56.7M | $213.5M | $78.3M | -$141.9M | -$41.4M |
Growth Trends (YoY %)
Last updated: Aug 31, 2026 2:36am (39d ago)| Metric | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Revenue Growth | +19.4% | +9.8% | +7.8% | +8.2% |
| Gross Profit Growth | +20.7% | +10.6% | +7.6% | +8.5% |
| Operating Income Growth | -42.3% | +135.9% | +532.0% | +49.3% |
| Net Income Growth | -39.3% | +175.9% | +1,343.5% | -71.1% |
| EBITDA Growth | -108.9% | +7,233.8% | +142.9% | +34.7% |
Deep Analysis
Risk : Reward — upside vs downside from this company's own quarters
Computed 2026-09-18 02:42A +1σ run of quarters pays -58%; a −1σ run costs 69%. Ratio -0.9:1 (μ 8.7%, σ 4.2% floored by sector, 16 pairs).
Older method (repeat-worst-quarter): 0.1 : 1
| Case | Growth | Margin | Fair value | vs price ($64.00) |
|---|---|---|---|---|
| Bull — recovery | +13% | 28.8% | $67.44 | +5% |
| Base — stabilizes | +9% | 25.1% | $51.31 | -20% |
| Bear — keeps slipping | +4% | 21.3% | $38.13 | -40% |
| Stress — last quarter repeats | +8% | 10.8% | $22.79 | -64% |
| Upside — a +1σ run of quarters (v2) | +13% | 10.8% | $26.68 | -58% |
| Stress — a −1σ run of quarters (v2) | +4% | 10.6% | $20.05 | -69% |
Narrative Economics
market-narrative step).
Growth Outlook
Analyzed 2026-08-31 02:54The question every valuation on this page silently assumes: is this company likely to grow? Judged forward — the business, its category, the world — against what's already printed.
Claude Reading
The trajectory here is more concerning than the "steady compounder" framing suggests. Sequential quarterly revenue went $800.6M → $818.4M → $836.9M → $830.2M — that's a sequential *decline* in the most recent quarter, and YoY growth has decelerated from double digits to roughly 8.7% ($830.2M vs $763.7M). Net income at $78.2M is down from $90.3M sequentially and margin compressed from 10.8% to 9.4%. For a company the synthesis calls a "mature earner priced for slow decline," the print already shows the deceleration the bears warned about. Annual revenue growth was 8.0% ($2.98B → $3.22B) and the LTM run-rate ($3.29B) implies barely 6-7% forward growth if Q1 weakness persists. The $1.07B FY25 net income figure is a tax-benefit artifact (note the July 2024 $888M quarter at 120% margin — that's a deferred tax asset release, not operations), so trailing PE of 43x is optically flattering; on cleaner ~$310M FY26 NI, PE is ~39x, and on operating income of $299M, EV/OI is ~39x. That is not cheap for 7% growth.
Where I disagree with the prior stack: the synthesis fair-value of $51.80 (signal-adjusted $56.69) and the Thesis Evaluation's "trough valuation" bull argument are in tension, and I side with the synthesis. FCF of $1.06B on a $12.2B market cap is a ~8.7% FCF yield — that's genuinely attractive *if* you believe FCF holds, but FCF is inflated by SBC add-back (the July 2026 award grants totaling ~600K+ shares to insiders confirm dilution is meaningful — at $64 that's ~$38M in a single day of grants, annualized this is a material charge the "adjusted" numbers hide). Real owner earnings are closer to $700-800M, putting the true FCF yield at 5.7-6.5% — fair, not cheap. The Market Forces "neutral" and Narrative layer's "12.9% premium is narrative" reads are directionally right but too generous; I'd argue the premium is closer to 20-25% versus a defensible DCF given the Q1 sequential decline.
The contrarian case that no model articulates forcefully enough: DocuSign has zero debt, $602M cash, $1.06B FCF, and is buying back stock aggressively (implied by flat-ish share count despite massive SBC). This is a legitimate LBO/strategic target — Adobe tried once, and at $12B market cap versus $1B+ FCF, a private equity take-out at $75-80 is mathematically feasible (6-7x EV/FCF post-deal). That optionality is real and asymmetric. The counter-contrarian point: the reason no one has bid since Adobe's 2018 rumor is that eSignature *is* being commoditized, and CLM/IAM (Intelligent Agreement Management) is unproven — Q1's sequential decline is the first hard evidence the platform pivot isn't yet offsetting core stagnation. Insider selling is minimal (450 + 15,000 shares) but the massive July award grants suggest management is loading up on equity right before what they may expect to be a re-rating — or they're just cashing in via RSU vesting mechanics. Ambiguous.
Data gaps worth flagging: the "2026" dates suggest fiscal-year labeling that's a full year ahead of calendar — this is DocuSign's fiscal calendar (FY ending Jan), so "Q1 2026" is actually the April 2025 quarter, meaning the freshest data point is ~6 months stale relative to real-time. The current price of $64 versus a 52-week high implying ~$86 means the market has already digested some deterioration. Current ratio of 0.73 looks alarming but is normal for SaaS with large deferred revenue — not a red flag. Net: I partially agree with the synthesis fair-value framework but think signal-adjusted $56.69 is slightly too bearish given the takeout floor; my fair value is $58-62, essentially where it trades. This is not a mispricing — it's a coin flip on whether IAM works, with a takeout put underneath around $55-58. No edge long or short at $64; I'd want $52 to buy for the FCF yield and takeout optionality, or $75+ to short on multiple compression risk.
GPT Reading
DocuSign looks less like a broken SaaS story than the market narrative implies, but also less like a bargain than a screen based on free cash flow alone would suggest. The raw operating data show a company that has already crossed the difficult part of the maturity transition: annual revenue rose from $2.11B in FY22 to $3.22B in FY26, an 11% four-year CAGR, while operating margin moved from -2.9% to +9.3%. The latest four quarters totaled about $3.29B of revenue, up roughly 9% year over year, and quarterly net margins have settled into a real 8-11% band rather than one-off profitability. Gross margin remains elite at 79.4%, and the balance sheet is unusually clean for software at this scale: no debt and $602M of cash. That combination matters because it means this is not a hope trade on future efficiency; the efficiency is already here.
What stands out most is the cash generation relative to the valuation. On FY26 numbers, DocuSign produced $1.17B of operating cash flow and $1.06B of free cash flow against a $12.22B market cap, an FCF yield of roughly 8.7%. Even allowing for stock comp and working-capital timing, that is a real cash machine for a software company still growing high single digits. EV/revenue of 3.7x and EV/EBITDA of 28.7x are not optically cheap if you insist on classic SaaS growth comps, but they look more than reasonable for a business with 20% ROIC, no leverage, and a recurring-revenue base that has kept quarterly revenue tightly clustered between $764M and $837M over the last six reported quarters. The stock at $64 is being priced like a no-growth annuity with mild erosion risk; the actual data show a business still compounding revenue and expanding profitability.
The main thing I do not like is that the growth profile is flatter than the cash flow profile, and that often hides the market's real concern. Sequentially, revenue peaked at $836.9M in January 2026 and slipped to $830.2M in April 2026; that is not alarming by itself, but it is consistent with a business that may have largely exhausted the easy monetization from its installed base. Annual revenue growth has also slowed from the pandemic-era trajectory to something closer to 8-9%. On reported earnings, the picture is noisier than the cash metrics suggest: FY25 net income of $1.07B is clearly distorted by the absurd $888.2M quarter at 120.7% margin, so the headline P/E of 43x is actually understating how expensive the stock looks versus normalized GAAP earnings power. If you normalize toward the more recent quarterly run-rate of roughly $315M annual net income, the equity is closer to high-30s to low-40s times sustainable earnings, not a clear steal for a company with single-digit top-line growth.
The strongest case against my constructive read is straightforward: if e-signature is genuinely commoditizing, then a 3.7x EV/sales multiple is not cheap at all, because the core business could drift from 8% growth to low single digits while pricing pressure prevents margin expansion from offsetting it. The current ratio of 0.73 also reminds you that this is not a fortress from a liquidity optics standpoint, even if cash generation makes that manageable. Bears would also point out that recent earnings growth is negative on the momentum snapshot, insider activity is not signaling conviction, and software peers with stronger product breadth can bundle adjacent workflow tools in ways DocuSign cannot. I weigh those points less heavily because the reported results so far do not show a collapsing moat: revenue has not rolled over, gross margin has not cracked, and free cash flow has not deteriorated. Commoditization is a thesis; the numbers still describe resilience.
What would change my mind is pretty specific. If the next two quarters show revenue growth slipping below 6% year over year while quarterly revenue stays stuck around $830M and net margin falls back below 8%, I would conclude the cash flow peak is being harvested from a stagnating core and $64 is too high. Conversely, if DocuSign can push back above $850M quarterly revenue with double-digit year-over-year growth and sustain annualized FCF above $1.0B without margin compression, then the current price will look too conservative and a mid-$70s valuation would be justified. Right now, the stock is modestly mispriced to the upside because the market is giving little credit for the fact that this is already a durable, debt-free software cash compounder rather than a deteriorating pandemic leftover.
Grok Reading
DocuSign’s raw financials describe a business that has completed the hard part of the SaaS maturity curve and is now throwing off cash at a rate the equity market is only partially crediting. Fiscal 2026 revenue reached $3.22B, up roughly 8% from $2.98B, with quarterly run-rates locked in the low-to-mid $800M band ($830M most recently after $837M). That growth is unexciting, yet the conversion is elite: $1.17B operating cash flow and $1.06B free cash flow on only $106M of capex produce a 33% FCF margin. Gross margin sits at 79.4%, operating margin has expanded to 9.3% from near-zero two years earlier, and the balance sheet carries zero debt against $602M cash. The 2025 net-income spike to $1.07B was clearly one-time noise (the July 2024 quarter alone booked an $888M profit); clean 2026 earnings of $309M still imply a trailing P/E near 43×, but that multiple is a distortion. On free cash flow the stock trades at roughly 11.5×, an 8.7% FCF yield for a sticky, high-gross-margin franchise growing high-single digits with no leverage. Sequential revenue dipped slightly and the current ratio of 0.73 is tight, yet ROIC of 20% and ROE of 16% confirm capital is being deployed productively. The numbers therefore tell a mature-earner story that is already self-funding and modestly compounding, not a fading growth story that deserves a discount.
The valuation models that spit out a mid-$50s fair value and an 11% overvaluation signal are overweighting the reported P/E and underweighting cash generation. At 3.7× EV/revenue and 4.2× sales, DocuSign sits well below typical profitable SaaS peers that still clear 6–8× sales; the 28.7× EV/EBITDA is elevated only if one ignores that EBITDA still embeds stock-based compensation and that true owner earnings are closer to the $1.06B FCF figure. Insider activity is noise—routine awards and small sales—while the 8% revenue CAGR and 9% FCF CAGR are consistent with a steady compounder rather than a value trap. The market narrative of “boring excellence” is therefore directionally correct, but the 13% premium the narrative engine frets about looks more like a modest discount once cash flow, not GAAP earnings, is the anchor.
The strongest opposing case rests on the deceleration itself and the competitive overlay. Revenue growth has slowed from the teens into the 8% zone, the latest quarter slipped sequentially, and secondary signals flag “decelerating” with macro headwinds and below-sector benchmarks. E-signature is genuinely susceptible to bundling by Microsoft and Adobe; if core volume growth settles at mid-single digits while CLM and analytics fail to offset, the 11.5× FCF multiple compresses toward 8–9× and the stock belongs in the low $50s. The thesis evaluation’s top bear weights—commoditization at 72 and unproven CLM moat at 58—are real risks, and the near-zero implied FCF growth the market is embedding could prove correct if enterprise IT budgets stay constrained. I weigh this less heavily because the installed base remains highly retained, switching costs on agreement workflows are non-trivial, and the company already generates more than a billion dollars of annual free cash with room for operating-margin expansion above the current 9%. Commoditization fears have been priced for several years; the cash flow statement has not broken.
Sustained quarterly revenue growth re-accelerating above 12% year-over-year, or clear evidence that CLM/AI attach is adding 200-plus basis points of growth, would push me decisively bullish and toward a mid-$80s valuation. Conversely, two consecutive quarters of sub-5% growth or an explicit loss of a top-25 enterprise logo to a bundled Microsoft/Adobe offering would flip the stance to overvalued and imply downside toward $50.
Qwen Reading local experiment · off-panel
The number that decides this case is the free cash flow: $1.06B on $3.22B of revenue, a 33% FCF margin, generated with zero debt and $602M of net cash. That is the engine, and it is real. The quarterly print confirms it — operating cash flow of $1.17B against capex of just $106M (3.3% of revenue) is the signature of a capital-light software toll-booth that has passed its investment phase. Revenue has grown from $2.11B (FY2022) to $3.22B (FY2026), a steady ~11% CAGR, and the last four same-quarter YoY comparisons all land in the 7.8–8.8% band. That is not "decelerating" in any alarming sense; it is a mature SaaS business compounding at a respectable clip. The "Revenue Confidence: decelerating" tag overstates the concern — the trend is flat-to-slightly-positive, not deteriorating.
The earnings picture requires one correction before any multiple is meaningful. The July 2024 quarter shows net income of $888.2M on $736M of revenue — a 120.7% margin that is a one-time item (almost certainly a deferred tax asset release or similar), not an operating result. That single quarter inflated FY2025 net income to $1.07B and makes the "earnings CAGR of 104.4%" and "recent earnings YoY of −71.1%" in the Momentum block pure artifacts. Strip it out and the clean run-rate is the FY2026 figure: $309M net income, $299M operating income, with the last seven non-distorted quarters averaging roughly $78M per quarter. The P/E on that clean base is $10.52B / $309M ≈ 34x, not the 37x the canonical metric shows (which is close but slightly off on the denominator). More usefully, the EV bridge is: $10.52B market cap minus $602M cash plus zero debt = $9.92B enterprise value. EV/FCF is 9.4x. EV/Revenue is 3.1x. For a SaaS company growing 8% with 33% FCF conversion and 20% ROIC, 9.4x FCF is at the low end of the 10–15x range that the sector commands for "mature but still growing" software names. The prior models' composite of $53.25 and signal-adjusted $59.00 bracket the current $55.09 price, and their "fair_value" verdict is directionally correct, though the $53.25 composite undershoots what the FCF multiple supports.
The genuine weakness is operating margin: 9.3% in FY2026, up from 1.1% in FY2024 and negative in 2022–23. For a business with 79% gross margin, a mature SaaS peer would be at 25–35% operating margin. The gap implies heavy R&D and S&M spend — either an investment in the CLM (contract lifecycle management) transition that has not yet paid down, or a competitive structure where pricing power is thinner than the "digital infrastructure" narrative suggests. The Market Forces layer's reference to Microsoft commoditization and AI disruption is the right risk to name, and the 36% drawdown from 52-week highs shows the market has already discounted some of that fear. The insider block is ten A-Award grants on a single date — compensation mechanics, zero informational content. The "Neutral Insider Activity" tag is accurate.
The strongest case against my read is the growth ceiling. Eight percent revenue growth on a $3.2B base is $250M of incremental revenue per year — meaningful, but it is not the 20%+ growth that justifies 20x+ FCF multiples. If the CLM transition stalls and core eSignature continues to commoditize, growth could drift to 4–5%, at which point 9.4x FCF becomes the floor, not the entry. The 9.3% operating margin also means that any further competitive pressure on pricing hits the bottom line directly, with no margin cushion. A bear applying 7x FCF (commodity software, 5% growth) gets EV of $7.4B, equity of $8.0B, or roughly $42/share — a 24% downside. That scenario is not implausible if Microsoft bundles e-signature into Teams at a loss-leader price.
What would change my mind in either direction: a quarterly print showing revenue growth reaccelerating above 12% (CLM traction) would push the fair multiple to 12–13x FCF and fair value toward $70+; conversely, two consecutive quarters of revenue growth below 6% or operating margin compressing below 7% would validate the 7x FCF bear case and $45 becomes the anchor. The next two earnings reports are the tripwire.
At $55.09, the stock is priced at 9.4x FCF with 10% FCF yield on an EV basis, net cash on the balance sheet, and 20% ROIC. That is not expensive for what it is. It is not a 30% upside opportunity either, because the growth rate caps the multiple. Fair value sits in the $60–68 range — modestly above the current price, but not by enough to call it a mispricing.
Big-3 Panel — where each AI stands
Advanced Analysis Forensic deep-dive · separate lenses
Revenue has compounded steadily from $2.11B (2022) to $3.22B (2026), gross margin sits at a software-elite 79.4%, and operating margin has swung from -2.9% to +9.3% over five years. Free cash flow is the real story: $445M to $1.06B, with OCF/NI at 1.1x, accruals at -18.4% of assets, and a Beneish M of -3.26 and Altman Z of 3.4 all pointing to clean earnings quality. The 2025 net income of $1.07B is inflated by a deferred tax valuation-allowance release (typical for a company crossing into sustained profitability); the 2026 print of $309M is the more honest run-rate, which still puts real GAAP earnings behind the FCF. Balance sheet is self-funding: $602M liquid cash, no net debt, and $1.06B annual FCF means the business does not need capital markets. Diluted share count grew from 196.7M to 210.3M over five years - a ~1.6% CAGR that is disciplined for a company this SBC-heavy, and the July 2026 award tape (Thygesen 319K, Grayson 134K, Hansen 134K, etc.) confirms SBC remains large and must keep being offset by buybacks to hold the line. Insider directional signal is neutral to mildly negative: two small S-Sales ($929K total) versus zero open-market buys, but nothing screams distribution. The bigger quality question is durability - e-signature is commoditizing (Adobe Sign, Dropbox Sign, native platform features), and the shift to 'Intelligent Agreement Management' is unproven. This is a healthy business today; the question is whether it stays one.
Verify before trusting this (6)
- Confirm the 2025 net income spike was driven by deferred tax valuation allowance release, not operating gains
- Actual buyback dollars vs SBC expense to verify per-share protection is sustainable
- Customer/enterprise retention (NRR/DBNR) trends and billings growth to test moat vs commoditization thesis
- Progress and monetization of Intelligent Agreement Management (IAM) platform pivot
- Customer concentration and international mix disclosed in 10-K
- Any convertible/debt terms - none flagged but worth confirming in filings
The composite fair value sits at $51.80 and the signal-adjusted FV at $56.69, both below the $64 price implying -11% to -19% downside to deserved value. The DCF outlier at $83 assumes growth reacceleration that the bear case (mid-single-digit normalization, Microsoft/Adobe pressure) directly challenges, while the EPV floor of $11 is a runaway pessimistic method; discarding both extremes, the anchored PE of $30 and signal-adj $56.69 bracket a deserved zone in the low-$50s. That's a modestly stretched price, not a bubble - the market is fairly paying up for a $1B+ FCF, net-cash software business with clean earnings quality.
Verify before trusting this (4)
- Billings and net-retention trajectory next print - is growth stabilizing or still decelerating
- IAM (Intelligent Agreement Management) contribution to new ARR - the reacceleration lever
- Stock-based comp as % of revenue and buyback pace vs dilution
- Enterprise win rates vs Adobe Sign / Microsoft in RFPs
DOCU is being repositioned in the tape from 'post-pandemic has-been' to 'AI-enabled agreement platform' after the Google Cloud Gemini Enterprise for Legal integration. News flow over the last 72 hours is uniformly on-narrative: three separate write-ups on the Gemini tie-in plus a group note lumping DOCU with Snowflake, Adobe and others as AI-benefiting enterprise software. That is the kind of narrative refresh that turns a sleepy steady-compounder story into something momentum accounts will at least look at, and it shows up in the recent 7.5% pre-earnings pop.
Verify before trusting this (4)
- Upcoming DOCU earnings print and any guide-up tied to AI/IAM monetization - the make-or-break for whether this narrative sticks
- Whether sell-side starts raising targets on the Gemini partnership or dismisses it as optical
- Any Microsoft/Adobe competitive response headline that would reintroduce the bear case
- Follow-through in the enterprise-SaaS-as-AI-beneficiary group trade
The world is still digitizing paper agreements, but the easy conversion happened in 2020-21; what remains is slower, more enterprise, more procurement-committee-driven. Simultaneously the software demand cycle is contracting and higher-for-longer rates suppress the transaction verticals that generate envelope volume. That combination argues for a durable but unexciting mid-single-digit top line rather than either collapse or reacceleration. The genuine open question is whether AI turns agreements into structured data that a workflow incumbent monetizes, or into a commodity output any model can produce — DocuSign's audit-trail, identity and legal-defensibility layer is the part machines do not casually replicate, and that is where its next decade of earnings power resides.
When we made this prediction on Aug 31, 2026, DOCU was $65.44. We expect it to be $60.00 by Mar 2027, and we consider it great value under $50.00. This is an early model (v0.6.0) — the direction is more reliable than the exact price. Made Aug 31, 2026.
Blue is our prediction, starting the day we made it. Grey is a slower route to the same place — the same destination, taking longer. Black is the actual price, so you can see how we are doing.
Post-Report Due Diligence NOTES
Evidence for a closer look, not a verdict — no score or designation on this page has been changed by it. Items marked material are ones where a conclusion above moves to the other side of the price.